Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  22nd Century Group Inc    XXII

SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
News SummaryMost relevantAll newsSector newsTweets

22nd Century : The Briefcase The Briefcase

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/14/2017 | 09:45am CEST

22nd Century Group CEO

to speak at tobacco forum

22nd Century Group Inc., a plant biotechnology company with a production plant in Mocksville, said that Henry Sicignano III, its chief executive, will speak at today's Global Tobacco & Nicotine Forum in New York City.

Sicignano will participate on a panel discussing future next-generation products.

The forum is noted for its exchange of global ideas and information for tobacco technologies and products. Attendees to the forum include public health advocates, policymakers, scientists and industry executives.

22nd Century, based in Clarence, N.Y., bought the cigarette-manufacturing equipment of defunct Renegade Tobacco Co. in 2013 for $3.22 million in a bankruptcy proceeding.

Richard Craver

Triad HealthCare Network adds medical directors

Triad HealthCare Network said Wednesday it has added Drs. Beth Hodges and Rob Reade as medical directors to its primary care division.

The network is a partnership between area health-care providers and Cone Health.

Cone said the doctors will provide "a physician's perspective in developing the network's various quality and savings initiatives."

Hodges is a family medicine doctor at Hodges Family Practice in Asheville. Reade is a family medicine doctor at Eagle Family Medicine @ Triad. Both will continue seeing patients.

Richard Craver

Lexington Dialysis Center gets state OK for facility

Lexington Dialysis Center has received conditional approval from state health regulators for its certificate-of-need application.

The group has applied to spend $4.72 million on building a new facility on the same site at 233 Anna Lewis Drive.

The group is affiliated with Wake Forest Baptist Medical Center.

High Point pharmaceutical company plans IPO

Axium Pharmaceuticals Inc., based in High Point, has submitted a regulatory filing for a proposed initial public offering of its Class A common stock.

The company plans to sell 50 million shares, while shareholders plan to sell 45.13 million shares. There is no underwriter of the IPO.

The asking price is projected to be 10 cents a share, with potential gross proceeds of $9.51 million, including $5 million for use by the corporation.

Axium focuses on utilizing drug delivery innovations for developing improved novel formulations and alternative dosage forms of existing biologically active molecules. Product candidates address various pharmaceutical markets, including neurological disorderss, infectious diseases and diabetes.

Richard Craver

© © Copyright 2017, Winston-Salem Journal, Winston-Salem, NC, source Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 22ND CENTURY GROUP INC
09/14 22ND CENTURY : The Briefcase The Briefcase
09/13 22ND CENTURY : to Speak at Global Tobacco & Nicotine Forum
08/23 22ND CENTURY : Technology is a “Game Changer”
08/17 22ND CENTURY : FDA's Plan to Lower Nicotine in Cigarettes Has Captured the Atten..
08/14 MONDAY SECTOR LAGGARDS : Cigarettes & Tobacco, Metals & Mining Stocks
08/12 22ND CENTURY : Q2 results mixed 22nd Century posts mixed second-quarter results;..
08/10 22ND CENTURY : FDA rules could help 22nd Century 22nd Century gains brighter spo..
08/09 22ND CENTURY : Files 2017 Second Quarter Report and Announces Conference Call to..
08/09 22ND CENTURY : Management's Discussion and Analysis of Financial Condition and R..
08/09 22ND CENTURY : FDA's Plan to Lower Nicotine in Cigarettes Has Captured the Atten..
More news
News from SeekingAlpha
09/14 PREMARKET GAINERS AS OF 9 : 05 am
09/05 22nd Century Group Could Win Big From FDA Plan To Reduce Nicotine In Cigarett..
08/24 The New North American Marijuana Stock Basket
08/10 PREMARKET GAINERS AS OF 9 : 05 am
08/09 22nd Century misses by $0.01, beats on revenue
Financials ($)
Sales 2017 16,7 M
EBIT 2017 -9,40 M
Net income 2017 -9,06 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 19,5x
Capi. / Sales 2018 15,2x
Capitalization 326 M
Chart 22ND CENTURY GROUP INC
Duration : Period :
22nd Century Group Inc Technical Analysis Chart | XXII | US90137F1030 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Henry Sicignano President, Chief Executive Officer & Director
James W. Cornell Chairman
John T. Brodfuehrer CFO, Treasurer & Principal Accounting Officer
Michael Robert Moynihan Vice President-Research & Development
Joseph Alexander Dunn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
22ND CENTURY GROUP INC177.06%326
WASTE MANAGEMENT, INC.10.00%34 323
REPUBLIC SERVICES, INC.17.25%22 526
WASTE CONNECTIONS INC-19.94%18 328
SUEZ ENVIRONNEMENT15.59%11 866
UMICORE23.82%8 968